转一篇文章，给白兔妈

Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.

https://khn.org/news/article/paxlovid-covid-sticker-shock-insurance/

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid. But the government plans to stop footing the bill within months, and millions of people who are at the highest risk of severe illness and are least able to afford the drug — the uninsured and seniors — may have to pay the full price.

……………

The U.S. government has so far purchased 20 million courses of Paxlovid, priced at about $530 each, a discount for buying in bulk that Pfizer CEO Albert Bourla called “really very attractive” to the federal government in a July earnings call. The drug will cost far more on the private market, although in a statement to KHN, Pfizer declined to share the planned price. The government will also stop paying for the company’s covid vaccine next year — those shots will quadruple in price, from the discount rate the government pays of $30 to about $120.

………

 

Most Purchased Covid Therapeutics Sit Unused

The U.S. bought nearly 25 million courses of Paxlovid, Lagevrio, and Evusheld. Most haven't been used yet, but the U.S. Department of Health and Human Services says that free supply will run out within months.

Paxlovid: a total of 20 million courses were purchased. 29% have been used. 15% have been delivered to pharmacies but not used. 56% are still unordered. Lagevrio: a total of 3 million courses were purchased. 27% have been used. 59% have been delivered to pharmacies but not used. 14% are still unordered. Evusheld: a total of 1.7 million courses were purchased. 38% have been used. 19% have been delivered to pharmacies but not used. 42% are still unordered.

 

Unordered

 

 

Delivered

 to pharmacies but not used

 

Used

 

Paxlovid

56%

15%

29%

20M

Lagevrio

14%

59%

27%

3M

Evusheld

42%

19%

38%

1.7M

Note: Each patient uses two courses of Evusheld. Data is as of Nov. 20, 2022.

Source: U.S. Department of Health and Human Services

 

Credit: Hannah Recht/KHN

  Embed

  Download image

 

 

 

所有跟帖： 

• 看下面那个图，政府采购的P药，只用了不到三成。钱都付过了，不用就便宜药厂了。 -fuz- ♂ (0 bytes) () 12/23/2022 postreply 10:19:51

• 利益输送就是这么简单。本来可以按需求发货，billing 的基本合同条款。 -julie116- ♀ (0 bytes) () 12/23/2022 postreply 10:52:55

• 药用不完也过期的。Paxloid 本来保质12月，FDA九月份延长到18个月 -GoGym- ♀ (0 bytes) () 12/23/2022 postreply 10:53:14

• 浪费的是纳税人的钱 -2008VGirl- ♀ (0 bytes) () 12/23/2022 postreply 11:21:23

• 的确浪费，但是也没办法。因为订药的时候就要说好数量，政府大概宁愿多定浪费也不敢少定不够用 -GoGym- ♀ (140 bytes) () 12/23/2022 postreply 13:48:43

• 可见美国政府已经代表人民向辉瑞支付了$106亿美元购买Paxlovid，不知不觉中每个男女老幼都给辉瑞送了$32刀。 -红烧茄子-- ♂ (0 bytes) () 12/23/2022 postreply 11:54:03

• 能不能要回$32?免费送也不要吃. -5181- ♂ (0 bytes) () 12/23/2022 postreply 12:59:36

• 研究新药需要大笔资金的，纳税人的钱就是花的，我有辉瑞股票，还在水下呢 -hz82000- ♀ (0 bytes) () 12/23/2022 postreply 13:25:03

• 药厂如果有回扣的话回扣一般只给用掉的部分。没消耗掉的拿不到回扣只能write off -julie116- ♀ (0 bytes) () 12/23/2022 postreply 16:06:22